- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0008196

Zavik Drugs Private Limited
About Zavik Drugs Private Limited
Data last updated:
Zavik Drugs Private Limited is a private limited company based in Chandigarh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 30 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC033451. Its GSTIN is 04AAACZ5388F1Z6 (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ankit Mittal and Suresh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 476 First Floor Motor Market. Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.81 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹2.39 Lakh (net margin 1.3%) and EBITDA of ₹5.18 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
Zavik Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0008196). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Zavik Drugs
Contact details
Zavik Drugs Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressScf 476 First Floor Motor Market. Manimajra, Chandigarh, India – 160101
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Zavik Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zavik Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zavik Drugs Private Limited, buy the company report.
Financials of Zavik Drugs Private Limited
FY 2025 filings availableZavik Drugs Private Limited reported revenue of ₹1.81 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zavik Drugs Private Limited, buy the company report.
Board of directors of Zavik Drugs Private Limited
Zavik Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Mittal | Director | 30 Dec 2011 | 14 Years 10 Months | Current |
| Suresh Kumar Also directs: Eviza Biotech Private Limited | Director | 30 Dec 2011 | 14 Years 10 Months | Current |
Peer comparison
Zavik Drugs Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indoglobal Cab & Chems Private Limited | ₹1.82 Cr (FY 2018) | 1539.0% | New Delhi, Delhi, India | |||
| Technicom Chemie (India) Limited | ₹1.81 Cr (FY 2024) | -20.0% | New Delhi, Delhi, India | |||
| Maxxus Agro Private Limited | ₹1.81 Cr (FY 2025) | 396.0% | Purnia East, Bihar, India | |||
| Zayb Industries Private Limited | ₹1.81 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Zavik Drugs Private Limitedthis company | ₹1.81 Cr (FY 2025) | ₹2.39 Lakh | 1.3% | -2.0% | Chandigarh, India | |
| Vaishnav Cotton Private Limited | ₹1.81 Cr (FY 2025) | -38.0% | Sendhwa, Madhya Pradesh, India | |||
| Besticides Minerals Private Limited | ₹1.81 Cr (FY 2024) | 262.0% | Hyderabad, Telangana, India | |||
| MSHP Industries Private Limited | ₹1.81 Cr (FY 2025) | 21.0% | Delhi, India | |||
| Mntex Synthetics Private Limited | ₹1.81 Cr (FY 2024) | -39.0% | Mumbai, Maharashtra, India | |||
| Calvin Additives Private Limited | ₹1.81 Cr (FY 2024) | 19.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Zavik Drugs Private Limited, buy the company report.
Auditor
Zavik Drugs Private Limited is audited by AmitKSharma& Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AmitKSharma& Associates | FY 2017 | 021287N |
Shareholding
The shareholding of Zavik Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Zavik Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zavik Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zavik Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zavik Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAACZ5388F1Z6 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zavik Drugs Private Limited, buy the company report.
Recent activity
Zavik Drugs Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Rajeev Matta ceased to be Director on 22 Jul 2014.
Frequently asked questions
Zavik Drugs is an active private limited company based in Chandigarh, India. The company works in wholesale, within the trading industry. It was incorporated on 30 December 2011 (15+ years old) and is registered under CIN U24232CH2011PTC033451.
Zavik Drugs has 2 current directors:
- Ankit Mittal - Director
- Suresh Kumar - Director
The latest financial statements of Zavik Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zavik Drugs is 04AAACZ5388F1Z6, registered in Chandigarh.
The CIN (Corporate Identification Number) of Zavik Drugs is U24232CH2011PTC033451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zavik Drugs was incorporated on 30 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Zavik Drugs by revenue are Indoglobal Cab & Chems Private Limited, Technicom Chemie (India) Limited, Maxxus Agro Private Limited, Zayb Industries Private Limited, Vaishnav Cotton Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Rajeev Matta ceased to be Director on 22 Jul 2014. Vikas Sharma ceased to be Director on 28 Mar 2014. Ankit Mittal was appointed as Director on 30 Dec 2011. Zavik Drugs has 4 board changes on record in total.
Yes, Zavik Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0008196).
The registered office of Zavik Drugs is at Scf 476 First Floor Motor Market. Manimajra, Chandigarh, India – 160101.
Zavik Drugs operates in the trading industry, in the wholesale segment.

